AstraZeneca reportedly offers up to $134/share in non-binding proposal for Rhythm Pharmaceuticals

Rhythm Pharmaceuticals shares rose on a report of an additional bidder. AstraZeneca reportedly offered as much as $134 a share in a non-binding proposal, including milestone payments, people familiar with the matter said.

Detected & updated continuously · Source: Nebula